University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 5 of 16
Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry
NCT01843140
Ovarian Reserve Testing in Female Young Adult Cancer Survivors
NCT01421095
Therapeutic Ketogenic Diet in Partial Hospital Program (PHP) Anorexia Nervosa
NCT06605027
Nicotinamide Riboside Supplementation in Chronic Kidney Disease
NCT07693543
Optimizing CBSST With Executive Function Training for Schizophrenia (R33)
NCT07658391
Personalized Ventilator Settings for Patients on ECMO
NCT07673250
Combining Social Network Strategies and Routine Substance Use Screening
NCT07414459
An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs
NCT06068283
CKM For Safe Use of SGLT2i in Type 1 Diabetes
NCT07211802
Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery
NCT07693270
IO Vancomycin Administration in TKA
NCT07633418
Real-world Trial of Individualized Precision Oncology
NCT07346209
Folate Study in Men With Advanced Prostate Cancer
NCT06536374
Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection
NCT06962657
Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
NCT07364071
Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement
NCT07369089
Postpartum Education Via Artificial Intelligence for Recovery and Loneliness: A Randomized Controlled Trial
NCT07223736
CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM
NCT07213258
Feasibility of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery
NCT06818708
Time Restricted Eating in Patients With Microalbuminuria
NCT06884059
Androgen Effects on the Reproductive Neuroendocrine Axis
NCT06450405
Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes
NCT06727071
Obstructive Sleep Apnea Treatment in Serious Mental Illness
NCT05457127
Using AI to Improve Sepsis Quality of Care in the Emergency Department
NCT07581340
Evaluating the Role of the Microbiome in Antidepressant Treatment in Adolescents.
NCT06633497
Food Is Medicine for Patients With Heart Failure
NCT06540118
Dose-Optimized and Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression
NCT06730841
GLP-1 Medicines and Mental Health Changes
NCT07368855
Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation
NCT06071715
Role of CBD in Improving Alexithymia
NCT05832281
Incentives for Physical Activity for Older Adults
NCT05948709
Managing Opioid Related Sleep Apnea With Acetazolamide
NCT06043830
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders
NCT05899348
Postpartum Integration of Vaccines and Contraception Trial
NCT05732142
Frequency and E-field Enhancement of ITBS for Depression (FREED)
NCT06003309
Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)
NCT05951023
Neuromodulation for Comorbid Hoarding Disorder and Depression
NCT05985356
Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
NCT05894655
Evaluation of a Novel Non-Invasive Automated Fractional Flow Reserve Software System in Patients With Coronary Artery Disease
NCT06183294
Stress and Neurofeedback in Anorexia Nervosa
NCT05834816
Cannabidiol to Reduce Anxiety Reactivity
NCT05823753
Peripheral Oxytocin and Touch
NCT05326776
Pulsed Shortwave Therapy for Postoperative Analgesia
NCT05796583
Acetazolamide in Persons With Type 1 Diabetes - Dose Finding
NCT05473364
Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
NCT06377501
Investigating KardioPAC Mobile App to Improve Physical Fitness Among Cardiac Rehabilitation Patients
NCT05643976
Healing Experiences of Adversity Among Latinos (HEALthy4You)
NCT05676281
Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health
NCT05616260
Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism
NCT05568927
Navigating Health Insurance Selection for IVF Benefits
NCT05663645
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.